Company Filing History:
Years Active: 2024
Title: Matthew Zatzman: Innovator in Cancer Research
Introduction
Matthew Zatzman is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of cancer research through his innovative work. His dedication to improving cancer diagnostics and treatment is evident in his patented invention.
Latest Patents
Matthew Zatzman holds a patent for a "System and method for cancer-cell specific transcription identification." This invention relates to a method that includes receiving nucleic acid data from one or more samples. It involves determining the variant allele fraction (VAF) of markers in ribonucleic acid (RNA) and deoxyribonucleic acid (DNA) within the nucleic acid data. The method compares the VAF of RNA relative to DNA for each of the markers. The output of this comparison quantifies cancer-cell specific changes in transcriptional output, serving as a marker for prognosis or therapeutic response in cancer. He has 1 patent to his name.
Career Highlights
Matthew Zatzman is affiliated with The Hospital for Sick Children, where he contributes to groundbreaking research in pediatric health. His work focuses on enhancing the understanding of cancer at the molecular level, which is crucial for developing targeted therapies.
Collaborations
Matthew collaborates with fellow researcher Adam Shlien, working together to advance their understanding of cancer biology and improve patient outcomes.
Conclusion
Matthew Zatzman's innovative approach to cancer research exemplifies the impact of dedicated inventors in the medical field. His work continues to pave the way for advancements in cancer diagnostics and treatment.